Furthermore, in our model, IFN-γ-licensed MSCs were also able to exert an anti-apoptotic effect on T-cells, indicating that the use of MSCs can potentially contribute to avoiding lymphopenia and immunodeficiency observed in critical cases of COVID-19. This evidence concerns the gene IFNG and immune system disorder.